Neoseptolete Combi Eukalyptus (Benzydamine Hydrochloride, Cetylpyridinium Chloride)

Benzydamine acts locally on inflamed oral tissues by stabilising cell membranes and inhibiting the release of prostaglandins and other inflammatory mediators. This results in reduced pain, swelling and redness without significant systemic anti‑inflammatory activity, making it suitable for short‑term relief of throat and mouth discomfort.

The appropriate dose is determined by a healthcare professional based on the patient’s age, severity of symptoms and overall health. The prescriber will specify the amount, frequency and duration of use on the product label or in the prescription, and patients should follow those instructions exactly.

Safety data for benzydamine and cetylpyridinium chloride in pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks with their physician before using the product, and the prescriber may decide to avoid it or use the lowest effective dose.

To place an order, visit the product page on gnhindia.com and submit an enquiry with the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and the necessary import documentation.

Compared with systemic NSAIDs such as ibuprofen, benzydamine provides a targeted local anti‑inflammatory effect with minimal systemic exposure, reducing the risk of gastrointestinal side effects. The added cetylpyridinium chloride offers antiseptic activity that many plain NSAID mouthwashes lack, making the combination useful for both pain relief and infection control.

The product should be stored at ambient temperature, preferably below 25 °C, in its original container. It must be kept away from moisture, direct sunlight and extreme heat. Ensure the cap is tightly closed after each use to maintain stability and prevent contamination.

Neoseptolete Combi Eukalyptus is taken orally as directed by a healthcare professional. The usual method involves measuring the recommended volume, swishing it gently in the mouth for a short period to cover the affected area, and then expectorating or swallowing as instructed on the label.

The most serious risks include allergic reactions such as rash, swelling, itching or difficulty breathing, and rare cases of severe oral ulceration or anaphylaxis. If any signs of a hypersensitivity reaction appear, the product should be discontinued immediately and medical attention sought.

Individuals with known hypersensitivity to benzydamine, cetylpyridinium chloride or any excipients in the formulation should avoid the product. It is also not recommended for children under two years of age unless a physician specifically advises its use, and patients with uncontrolled oral infections should seek professional evaluation before treatment.